Kenvue Inc. (KVUE) carries a Roarable Rating of C+ (Hold) with 67/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Kenvue Inc. (KVUE) advanced +1.19% to $19.56 as options desks priced 55% call premium vs. 45% put protection around the $19 max-pain magnet. Solid 58% profit margin (12% return on capital), mixed timing at 26x P/E—hold if owned, no rush to chase.
Kimberly-Clark has climbed 10.8% over the past month, which puts fresh attention on a basic question for anyone looking at the shares today: whether that move lines up with the cash flows the business is expected to prod
Okta can expect a new pool of buyers for its stock as a member of the S&P 500. Kenvue is being acquired and will therefore depart the index.
Investing.com -- Okta Inc (NASDAQ:OKTA) shares climbed 2.1% in extended trading Friday after S&P Dow Jones Indices selected the identity and access management provider to join the benchmark S&P 500 index. The after-hours
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400, S&P SmallCap 600 effective prior to the opening of trading on Wednesday, November 4:
Market Domination Overtime Host Jared Blikre keeps track of several stocks moving in extended-hours trading after releasing earnings results, including AstraZeneca (AZN), AbbVie (ABBV), and Kenvue (KVUE).
Why Kimberly-Clark’s new debt deal matters for equity investors Kimberly-Clark (KMB) just closed a private offering of US$4.9b in senior unsecured notes, a sizeable funding move tied directly to its proposed acquisition
Wall Street holds or sells every one of these four blue chips, yet each has raised its dividend every single year and yields at least 4.35%. Find out why the analyst skepticism may be beside the point for income investor
Kenvue Q3 2026: revenue in line, adjusted EPS below estimates, but organic growth, margin gains and strong cash flow ahead of Kimberly-Clark deal.
Investing.com -- Kenvue Inc. (NYSE: KVUE) reported third-quarter results that missed analyst profit expectations despite revenue growth, as the consumer health company posted adjusted earnings per share of $0.29 compared
Kimberly-Clark (NasdaqGS:KMB) priced a US$4.9b multi-tranche senior notes offering to help fund its proposed Kenvue acquisition. The issuance includes several maturities, forming a new layer in Kimberly-Clark's long term
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. -2.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on KVUE today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for KVUE. Explore sector supply chains on /butterfly.
Why KVUE Stock advanced +1.19% Today — RQD Quant Desk Flash. Solid 58% profit margin (12% return on capital), mixed timing at 26x P/E—hold if owned, no rush to chase.